BIOVIE INC.

Develops drug therapies for Alzheimer's, Parkinson's, and advanced liver diseases by targeting inflammation.

BIVI | US

Overview

Corporate Details

ISIN(s):: US09074F4054
LEI:
Country:: United States of America
Address:: 680 W NYE LANE, 89703 CARSON CITY
Website:: https://www.bioviepharma.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioVie Inc. is a clinical-stage biopharmaceutical company developing innovative drug therapies for chronic debilitating conditions, with a primary focus on neurological, neurodegenerative, and advanced liver diseases. The company's scientific approach posits that inflammation is a central factor in the progression of these disorders. Its lead therapeutic candidate, bezisterim, is a novel molecule being studied for the treatment of Alzheimer's and Parkinson's disease, aiming to modulate inflammation and enhance brain energy transfer. BioVie is also developing treatments for ascites, a common and life-threatening complication of advanced liver cirrhosis. The company's research incorporates advanced science, including the study of epigenetic mechanisms like DNA methylation to regulate gene expression.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BIOVIE INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOVIE INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for BIOVIE INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
MYUNGMOON PHARM CO.,LTD Develops, manufactures, and commercializes prescription & OTC medicines for global markets.	South Korea	017180
Nanexa AB Develops long-acting injectables using its proprietary nanotechnology for its own pipeline and partners.	Sweden	NANEXA
Nanobiotix Develops a first-in-class radioenhancer to amplify radiotherapy's effect directly within tumors.	France	NANO
Nanobiotix S.A. Developing a nanotherapeutic radioenhancer that amplifies radiation to destroy solid tumors.	United States of America	NBTX
Nanoform Finland OYJ Pharma tech firm engineering nanoparticles to enhance drug performance and development.	Finland	NANOFH
NanoGroup S.A. Develops patented nanotechnology for oncology and transplantology diagnostics and therapies.	Poland	NNG
NanoRepro AG Develops and distributes rapid diagnostic self-tests for early disease detection.	Germany	NN6
NANOVIRICIDES, INC. Developing biomimetic nanomachines as broad-spectrum drugs to neutralize viral infections.	United States of America	NNVC
Nasus Pharma Ltd Develops powder-based intranasal drugs for rapid delivery in acute medical emergencies.	United States of America	NSRX
NATAC Develops sustainable plant extracts for nutraceutical, pharma, food, and animal nutrition industries.	Spain	NAT